December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
Based on market forecasts, the global cell cycle analysis market, projected at USD 22.51 billion in 2024, is expected to reach USD 63.94 billion by 2034, growing at a CAGR of 11.02% over the forecast period. The cell cycle analysis market is expanding due to growing innovations in flow cytometry as well as rising advances in genetic research. North...
November 01, 2025
Projections indicate that, the global cell & gene therapy quality control market will increase from USD 2.28 billion in 2024 to USD 22.81 billion by 2034, experiencing a CAGR of 25.74% over the next 10 years.The cell & gene therapy quality control market is growing due to it plays a significant role in ensuring that any cell or gene therapy...
November 01, 2025
Market insights predict, the portable bioprocessing bioreactors industry is expected to grow from USD 2.95 billion in 2024 to USD 7.25 billion by 2034, driven by a CAGR of 9.37%. The market is growing due to rising demand for flexible, small-scale biomanufacturing solutions in personalized medicine and biologics. Advancements in single-use technolo...
November 01, 2025
Market insights predict the global life science reagents industry will increase from USD 62.34 billion in 2024 to USD 108.74 billion by 2034, achieving a CAGR of 5.74%. The life science reagents market is growing due to rising demand for personalized medicine. North America is leading due to the focus on developing biologics....
November 01, 2025
Projections indicate that, the global immortalized cell line market will increase from USD 4.55 billion in 2024 to USD 8.68 billion by 2034, experiencing a CAGR of 6.71% over the next 10 years.The market is growing due to increasing demand for stable, reproducible cell models in drug development and biomedical research. Their ability to divide inde...
November 01, 2025
Based on market forecasts, the live cell imaging sector will expand from USD 2.92 billion in 2024 to USD 6.49 billion by 2034, experiencing a CAGR of 8.34%.The live cell imaging market is growing due to this imaging allows researchers to observe and document the behaviour of living cells over time, offering a dynamic standpoint on cellular processe...
November 01, 2025
According to market projections, the stem cell assay sector is expected to grow from USD 2.68 billion in 2024 to USD 13.5 billion by 2034, reflecting a CAGR of 17.55%. The stem cell assay market is expanding due to increasing stem cell research as well as rising stem cell-based products and therapies. North America led the market due to advancement...
November 01, 2025
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the geriatric population, lifestyle choices (smoking, diet), and environmental factors are driving the g...
November 01, 2025
Market insights predict the global non-sterile compounding pharmacy industry will increase from USD 5.97 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 7.34%. The rise in OTC drug demand is driving the non-sterile compounding pharmacy market. North America dominates due to the strong presence of pharmaceutical key players. ...
November 01, 2025
According to market projections, the global host cell protein testing market, valued at USD 2.37 billion in 2024, is anticipated to reach USD 5.19 billion by 2034, growing at a CAGR of 8.17% over the next decade. The growing demand for biologics and stringent regulatory policies drive the market. North America led the global market owing to the pre...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com